Compare OMH & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OMH | ACON |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6M | 5.0M |
| IPO Year | 2022 | 2022 |
| Metric | OMH | ACON |
|---|---|---|
| Price | $4.97 | $1.59 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | ★ $7.63 |
| AVG Volume (30 Days) | ★ 7.9M | 12.9K |
| Earning Date | 09-10-2026 | 11-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 99.82 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $75,730.00 |
| Revenue This Year | $39.14 | $44.55 |
| Revenue Next Year | $145.74 | $123.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 65.62 |
| 52 Week Low | $0.06 | $1.54 |
| 52 Week High | $94.60 | $9.36 |
| Indicator | OMH | ACON |
|---|---|---|
| Relative Strength Index (RSI) | 47.89 | 33.47 |
| Support Level | $1.00 | N/A |
| Resistance Level | N/A | $3.54 |
| Average True Range (ATR) | 14.69 | 0.11 |
| MACD | -0.18 | -0.01 |
| Stochastic Oscillator | 2.28 | 9.62 |
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.